Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Peripheral Embolic Protection Devices are used to capture and remove plaque debris that are dislodged during interventional procedures.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Peripheral Embolic Protection Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Peripheral Embolic Protection Devices Overview
Products under Development
Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table Peripheral Embolic Protection Devices - Pipeline Products by Segment
Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table Peripheral Embolic Protection Devices - Pipeline Products by Territory
Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Table EMBLOK Embolic Protection System - A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK Embolic Protection System During Transcatheter Aortic Valve Replacement
Table SwitchGuard Neuroprotection System - A Study to Evaluate the Efficacy of SwitchGuard Neuroprotection System in Transcarotid Artery Revascularization Procedures
Table Embrace Hydrogel Embolic System - A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries
Table Embrace Hydrogel Embolic System - Randomized Multi-center, Subject and Evaluator Blinded, Parallel-group Study to Evaluate the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) Compared with Standard of Care
Javelin Medical Ltd Company Overview
Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Jul 30, 2024: Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
Jul 02, 2024: Penumbra Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
Jun 13, 2024: Medtronic Confirms Global Layoffs
May 14, 2024: Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study
Apr 02, 2024: Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
Mar 12, 2024: Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Mar 04, 2024: Rapid Medical Receives DeNovo Clearance for BraidE Embolization Assist Device
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 12, 2024: InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard Neuroprotection System
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Dec 20, 2023: InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard Neuroprotection System
Nov 15, 2023: New Published Study Demonstrates Safety and Feasibility of Filterlex Medical's CAPTIS Device in Providing Embolic Protection During TAVR
Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference